1/3 of Research Presentations Highlight REV-MED Products, Establishing Its Role as a Comprehensive Stem Cell Therapy Platform Company
A significant portion of stem cell-related clinical presentations at the Korean Society of Stem Cell Therapy Autumn Conference featured REV-MED products.
Held recently at the AT Center in Seoul’s Yangjae-dong, the conference reflected heightened interest in stem cell therapy, driven by the enactment of the Advanced Regenerative Medicine and Advanced Biopharmaceuticals Act. The event showcased various research findings and clinical case studies.
Notably, in-depth studies on adipose-derived and bone marrow stem cells were presented, alongside a surge of interest in blood stem cells, which captured significant attention.
Dr. Gunwoo Kim from Le Diamant Clinic shared multiple clinical outcomes using NovaStem to explore the diverse potential applications of blood stem cells, providing insights into future advancements in the field.
Among the 15 lectures presented at the conference, five were based on clinical studies utilizing REV-MED products.
A representative from REV-MED stated, "These presentations reaffirmed our standing as the only biomedical company in Korea manufacturing medical devices for extracting stem cells from adipose tissue, bone marrow, and blood."
The representative added, "Having solidified our position as a company with an integrated platform for stem cell therapy medical devices, we will continue to make every effort to expand treatment opportunities for patients."
Source : DailyMedi https://www.dailymedi.com/news/news_view.php?wr_id=916712
1/3 of Research Presentations Highlight REV-MED Products, Establishing Its Role as a Comprehensive Stem Cell Therapy Platform Company
A significant portion of stem cell-related clinical presentations at the Korean Society of Stem Cell Therapy Autumn Conference featured REV-MED products.
Held recently at the AT Center in Seoul’s Yangjae-dong, the conference reflected heightened interest in stem cell therapy, driven by the enactment of the Advanced Regenerative Medicine and Advanced Biopharmaceuticals Act. The event showcased various research findings and clinical case studies.
Notably, in-depth studies on adipose-derived and bone marrow stem cells were presented, alongside a surge of interest in blood stem cells, which captured significant attention.
Dr. Gunwoo Kim from Le Diamant Clinic shared multiple clinical outcomes using NovaStem to explore the diverse potential applications of blood stem cells, providing insights into future advancements in the field.
Among the 15 lectures presented at the conference, five were based on clinical studies utilizing REV-MED products.
A representative from REV-MED stated, "These presentations reaffirmed our standing as the only biomedical company in Korea manufacturing medical devices for extracting stem cells from adipose tissue, bone marrow, and blood."
The representative added, "Having solidified our position as a company with an integrated platform for stem cell therapy medical devices, we will continue to make every effort to expand treatment opportunities for patients."
Source : DailyMedi https://www.dailymedi.com/news/news_view.php?wr_id=916712